Enoxaparin is a type of low-molecular-weight heparin used during pregnancy.
It is an FDA Class B drug for pregnant women with a history of thrombosis or
stillbirth, or for women with preeclampsia or recurrent miscarriages.
In accordance with heparin can not only improve blood circulation, anticoagulant and fibrinolytic system, also can suppress the immune, implantation and pregnancy sac prevention of preeclampsia, all can use in pregnancy and lactation period, in general, 1 ~ 2 times a day, subcutaneous injection, they appear less adverse reaction, but due to individual differences, may also appear a few adverse reactions, such as allergies, vaginal bleeding, subcutaneous ecchymosis, childbirth and postpartum hemorrhage, liver damage cause elevated liver enzymes, thrombocytopenia, hair loss, osteoporosis, and so on and so forth.
During the treatment period, it is recommended to monitor blood routine, urine routine, liver and kidney function, D2, platelet aggregation rate, or thromboelastics, etc., every 1-8 weeks. Patients with moderate or severe adverse reactions should be stopped, and should be stopped at least 24 hours before delivery.